Clinical Quality Improvement Partnership

Leverage Research Network Partnership and Help Improve Clinical Quality

Veradigm and the American College of Cardiology

Veradigm and the American College of Cardiology (ACC) are partnering to improve care and advance the next-generation of real-world research.

The partnership creates a large-scale chronic disease networks with more than:

This network powers research for Life Science companies. In addition, the network will be leveraged by the ACC to inform guidelines and enhance programs.

The partnership between Veradigm and the ACC can help you:

  • Power research efforts around cardiovascular and diabetes care
  • Examine critical questions on care delivery and outcomes
  • Gain insights from data with appropriate consent pulled directly from the provider’s Electronic Health Record (EHR)

For more information about Veradigm’s data, research and analytics capabilities for Life Science:

Contact Us

Delivering Cardiovascular Information at the Point-of-Care

Veradigm and the ACC are working together to take the complexity of cardiovascular medicine and simplify it in ways that enable doctors to have the right information at the right time to make the best decisions for their patients.

Therapeutic inertia refers to the failure to advance therapy (or to de-intensify therapy) at the appropriate time. This phenomenon is caused by many factors, but it is known to contribute to poorer outcomes for patients due to delayed treatment, sometimes by many years*. The ACC and Veradigm are working to address this issue.

Patient Data can be analyzed to understand how care is being delivered and to identify areas of opportunity where treatment best practices aren’t being followed (geography, provider type, patient population, etc.). Based on this analysis, the ACC can then direct quality improvement programs, education programs and other interventions for targeted populations. Post implementation, additional data can be collected to understand program effectiveness and identify areas of further improvement.

*Clinical Diabetes 2019 Apr; 37(2): 105-106.

Advancing Next Generation Research in Cardiovascular and Diabetes Care

As part of the partnership with the ACC, Veradigm now operates the PINNACLE Registry and the Diabetes Collaborative Registry. Life science researchers have access to the largest combined cardiovascular database and one of the largest metabolic database, with over 20 million patients, for a variety of scientific studies.


The PINNACLE Registry® is cardiology's largest outpatient quality improvement registry, capturing data on coronary artery disease, hypertension, heart failure and atrial fibrillation.


The Diabetes Collaborative Registry® is the first clinical ambulatory registry aimed at tracking and improving the quality of diabetes and cardiometabolic care across the primary and specialty care continuum. It provides a longitudinal view of the presentation, progression, management and outcomes of patients with diabetes as they receive care and treatment from multidisciplinary care teams. This interdisciplinary effort is led by Veradigm and the American College of Cardiology in partnership with the American Diabetes Association, the American College of Physicians, the American Association of Clinical Endocrinologists and the Joslin Diabetes Center.

To date, PINNACLE Registry and Diabetes Collaborative Registry research has been used to highlight real-world impacts of new clinical guidelines and identify where gaps in evidence-based care exist.

For more information about leveraging PINNACLE Registry and Diabetes Collaborative Registry for research.

Contact us

Contact 1
Hi! Looking to learn more about Clinical Quality Improvement Partnership?

Which Biopharma and Device products are you interested in?

Which Health Plans and Payers products are you interested in?

Which Healthcare Providers products are you interested in?

Which Health IT Partners products are you interested in?

It looks like you're interested in Clinical Quality Improvement Partnership. Please provide some final details:

1 of 4